+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
End Stage Renal Disease Market by Treatment Modality (Hemodialysis, Peritoneal Dialysis, Transplant), Access Type (Arteriovenous Fistula, Central Venous Catheter, Synthetic Graft), End User - Global Forecast 2025-2030- Product Image
End Stage Renal Disease Market by Treatment Modality (Hemodialysis, Peritoneal Dialysis, Transplant), Access Type (Arteriovenous Fistula, Central Venous Catheter, Synthetic Graft), End User - Global Forecast 2025-2030- Product Image
Sale

End Stage Renal Disease Market by Treatment Modality (Hemodialysis, Peritoneal Dialysis, Transplant), Access Type (Arteriovenous Fistula, Central Venous Catheter, Synthetic Graft), End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337854
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The End Stage Renal Disease market is experiencing significant transformation as clinical advances, regulatory shifts, and evolving patient needs converge. Senior decision-makers face a complex landscape where operational efficiency, technology integration, and innovative care delivery are critical to success.

Market Snapshot: End Stage Renal Disease Market Size & Growth

The End Stage Renal Disease Market grew from USD 53.09 billion in 2024 to USD 61.04 billion in 2025. It is expected to continue growing at a CAGR of 14.84%, reaching USD 121.83 billion by 2030. Stakeholders are responding to rapid market expansion through supply chain innovation, technology adoption, and patient-centered approaches. The primary keyword, "End stage renal disease," defines the current focus for care providers and market entrants alike.

Scope & Segmentation of the End Stage Renal Disease Market

This report delivers a granular breakdown of the market by modalities, technologies, access types, end users, geographies, and leading companies. Detailed segmentation helps inform precision strategies that optimize care outcomes and operational agility.

  • Treatment Modality: Hemodialysis (home, in-center), peritoneal dialysis (continuous ambulatory, continuous cycling), and transplantation (deceased donor, living donor) are analyzed for uptake, patient suitability, and evolving best practices.
  • Access Type: Arteriovenous fistula, central venous catheter, and synthetic graft categories are explored for durability, infection risk, and diverse patient profiles.
  • End User: Dialysis centers, home care settings, and hospitals highlight shifting care environments, with emphasis on multidisciplinary integration and training requirements.
  • Regional Coverage: Americas (with state-level insight in the United States), Europe, Middle East & Africa (including key national markets), and Asia Pacific (featuring growth drivers in major economies) are examined for disparities, healthcare infrastructure, and expansion opportunities.
  • Leading Companies: Profiles include Fresenius Medical Care, DaVita, Baxter International, B. Braun Melsungen, Nipro, NxStage Medical, U.S. Renal Care, Satellite Healthcare, Dialysis Clinic, and Jafron Biomedical, with an emphasis on strategies advancing competitiveness.

Key Takeaways for Strategic Decision-Makers

  • Technological progress, especially in remote monitoring, data analytics, and digital health solutions, is accelerating precision and efficiency in disease management while supporting regulatory compliance initiatives.
  • Providers and payers are realigning operational models to adapt to evolving reimbursement structures and an increased focus on value-based care delivery and patient-centered outcomes.
  • Growth in home-based therapies is reshaping resource allocation and staff training, requiring robust supply chains and enhanced digital support for remote patient monitoring and follow-up.
  • Differences in regional healthcare infrastructure, policy, and payment systems influence competitive positioning and market entry strategies, underlining the need for tailored solutions in diverse geographies.
  • Strategic alliances, joint ventures, and investments in R&D continue to drive innovation, from bioartificial kidney research to next-generation filtration and wearable device pilots.

Tariff Impact and Supply Chain Considerations

The implementation of new United States tariffs in 2025 created supply chain and cost challenges for the sector. Manufacturers are prioritizing localized sourcing and domestic assembly to maintain continuity, while cooperative procurement among healthcare networks aims to optimize purchasing power. Stakeholders are rebalancing cost structures and reviewing access strategies to protect patient affordability and ensure reliable therapy delivery.

Methodology & Data Sources

This analysis is underpinned by a blend of structured interviews with domain experts, quantitative surveys across diverse care settings, and rigorous secondary research of regulatory documents and market databases. Scenario modeling, benchmarking, and validation exercises reinforce the credibility and applicability of the findings for executive strategy setting.

Why This Report Matters for Senior Leaders

  • This research enables informed, proactive decision-making by consolidating clinical, operational, and regulatory insights across all major regional markets.
  • Actionable strategies outlined within support supply chain resilience, cost containment, and the integration of advanced technologies, addressing both immediate and future operational imperatives.
  • In-depth segmentation provides a roadmap for tailoring investments and care models to specific patient needs and market dynamics, enhancing competitive differentiation.

Conclusion

Today’s End Stage Renal Disease market demands agile responses to changing technologies, policy requirements, and patient preferences. This report distills current developments to help executives shape robust, forward-thinking strategies in a rapidly evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of home hemodialysis driven by telehealth integration to improve patient adherence and reduce hospitalization rates
5.2. Emergence of wearable artificial kidneys designed for ambulatory dialysis to enhance patient mobility and quality of life
5.3. Increasing utilization of precision medicine biomarkers to predict residual renal function decline and personalize treatment regimens
5.4. Rising investments in peritoneal dialysis infrastructure to address increasing demand in emerging markets and reduce healthcare costs
5.5. Integration of artificial intelligence algorithms in dialysis machines for real time monitoring and predictive maintenance alerts
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. End Stage Renal Disease Market, by Treatment Modality
8.1. Introduction
8.2. Hemodialysis
8.2.1. Home
8.2.2. Incenter
8.3. Peritoneal Dialysis
8.3.1. Continuous Ambulatory Peritoneal Dialysis
8.3.2. Continuous Cycling Peritoneal Dialysis
8.4. Transplant
8.4.1. Deceased Donor
8.4.2. Living Donor
9. End Stage Renal Disease Market, by Access Type
9.1. Introduction
9.2. Arteriovenous Fistula
9.3. Central Venous Catheter
9.4. Synthetic Graft
10. End Stage Renal Disease Market, by End User
10.1. Introduction
10.2. Dialysis Centers
10.3. Home Care Settings
10.4. Hospitals
11. Americas End Stage Renal Disease Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa End Stage Renal Disease Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific End Stage Renal Disease Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Fresenius Medical Care AG & Co. KGaA
14.3.2. DaVita Inc.
14.3.3. Baxter International Inc.
14.3.4. B. Braun Melsungen AG
14.3.5. Nipro Corporation
14.3.6. NxStage Medical, Inc.
14.3.7. U.S. Renal Care, Inc.
14.3.8. Satellite Healthcare, Inc.
14.3.9. Dialysis Clinic, Inc.
14.3.10. Jafron Biomedical Co., Ltd.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. END STAGE RENAL DISEASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. END STAGE RENAL DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. END STAGE RENAL DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. END STAGE RENAL DISEASE MARKET: RESEARCHAI
FIGURE 22. END STAGE RENAL DISEASE MARKET: RESEARCHSTATISTICS
FIGURE 23. END STAGE RENAL DISEASE MARKET: RESEARCHCONTACTS
FIGURE 24. END STAGE RENAL DISEASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. END STAGE RENAL DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY INCENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY INCENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY CONTINUOUS CYCLING PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY CONTINUOUS CYCLING PERITONEAL DIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY DECEASED DONOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY DECEASED DONOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY LIVING DONOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY LIVING DONOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY CENTRAL VENOUS CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY CENTRAL VENOUS CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY SYNTHETIC GRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY SYNTHETIC GRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL END STAGE RENAL DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES END STAGE RENAL DISEASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 80. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 81. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 82. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 83. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 84. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 85. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 86. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 87. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 88. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 89. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. CANADA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 92. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 93. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 94. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 95. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 96. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 97. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 98. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 99. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 100. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 154. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 155. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 156. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 157. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 158. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 159. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 160. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 161. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 162. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 163. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 166. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 167. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 168. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 169. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 170. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 171. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 172. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 173. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 174. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 175. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. FRANCE END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 190. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 191. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 192. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 193. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 194. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 195. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 196. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 197. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 198. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 199. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ITALY END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 202. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 203. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 204. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 205. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 206. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 207. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 208. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 209. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 210. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 211. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. SPAIN END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 250. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 251. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 252. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 253. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 254. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 255. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 256. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 257. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 258. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 259. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. DENMARK END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 274. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 275. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 276. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 277. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 278. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 279. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 280. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 281. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 282. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 283. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. QATAR END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 286. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 287. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 288. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 289. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 290. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 291. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 292. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 293. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 294. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 295. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. FINLAND END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA END STAGE RENAL DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 322. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 323. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
TABLE 324. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY HEMODIALYSIS, 2025-2030 (USD MILLION)
TABLE 325. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
TABLE 326. EGYPT END STAGE RENAL DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • NxStage Medical, Inc.
  • U.S. Renal Care, Inc.
  • Satellite Healthcare, Inc.
  • Dialysis Clinic, Inc.
  • Jafron Biomedical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 61.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 121.83 Billion
Compound Annual Growth Rate14.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

End-Stage Renal Disease - Global Strategic Business Report - Product Image

End-Stage Renal Disease - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From
End Stage Renal Disease Drug Pipeline Analysis Report 2025 - Product Image

End Stage Renal Disease Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Continuous Renal Replacement Therapy Market by Product Type (CRRT Accessories, CRRT Consumables, CRRT Systems), Modality (Hemodiafiltration, Hemodialysis, Hemofiltration), Application, End User - Global Forecast 2025-2030 - Product Image

Continuous Renal Replacement Therapy Market by Product Type (CRRT Accessories, CRRT Consumables, CRRT Systems), Modality (Hemodiafiltration, Hemodialysis, Hemofiltration), Application, End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
End-Stage Kidney Disease - Pipeline Insight, 2025 - Product Image

End-Stage Kidney Disease - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Diabetic Nephropathy Treatment Market by Treatment Type (Pharmacological, Renal Replacement Therapy), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Route Of Administration, Disease Stage, Patient Population - Global Forecast 2025-2030 - Product Image

Diabetic Nephropathy Treatment Market by Treatment Type (Pharmacological, Renal Replacement Therapy), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Route Of Administration, Disease Stage, Patient Population - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From

About the End Stage Renal Disease Drug Market

End Stage Renal Disease (ESRD) Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. ESRD drugs are used to treat patients with advanced kidney failure, who require dialysis or a kidney transplant. These drugs are used to reduce the symptoms of kidney failure, such as anemia, high blood pressure, and bone disease. They also help to reduce the risk of complications from dialysis and kidney transplantation. Common ESRD drugs include erythropoietin, calcitriol, and iron supplements. The ESRD Drug market is highly competitive, with many companies offering a variety of products. Major players in the market include Amgen, AstraZeneca, Baxter, Fresenius Medical Care, and Novartis. Other companies in the market include AbbVie, Allergan, Daiichi Sankyo, and Merck. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.